PUBLISHER: Grand View Research | PRODUCT CODE: 1571655

PUBLISHER: Grand View Research | PRODUCT CODE: 1571655

Ophthalmic Viscosurgical Devices Market Size, Share & Trends Analysis Report By Type (Dispersive, Cohesive Viscoadaptive), By Source (Animal, Biological & Semi-synthetic), By Application, By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED: September 19, 2024

PAGES: 100 Pages

DELIVERY TIME: 2-10 business days

ADD TO COMPARE

SELECT AN OPTION

Description

Ophthalmic Viscosurgical Devices Market Growth & Trends:

The global ophthalmic viscosurgical devices market size is anticipated to reach USD 639.5 million by 2030, registering a CAGR of 6.3% from 2024 to 2030, according to a new report published by Grand View Research, Inc. Steady rise in geriatric population coupled with high prevalence of ocular disorders is expected to drive the growth. Constantly developing ophthalmic care facilities are expected to contribute to the demand for Ophthalmic Viscosurgical Devices (OVDs) in near future.

Increasing prevalence of diabetes is expected to be a major factor boosting the market growth. Patients with both type 1 and type 2 diabetes are prone to develop cataract at some point in time. Currently, the surgical procedure is the only treatment option for cataract, thereby driving the demand for ophthalmic viscosurgical devices-an integral part of the cataract surgery. Furthermore, the global burden of cataract can be subjected to the increasing Cataract Surgical Rate (CSR) in countries, such as India, Japan, U.S., and several Western European countries.

Favorable government and non-government initiatives, such as ophthalmic screening programs, state and national eye care schemes, ophthalmic training, and education programs are expected to play a significant role in the ophthalmic viscosurgical devices market growth. For instance, the World Diabetes Foundation conducts training and development programs for ophthalmic HCP at primary care in regions of underdeveloped economies, improving the reach and awareness of cataract treatment procedures.

Developing advanced viscoelastics such as super-cohesive and viscoadpative OVD suitable for each stages of routine and complex ocular surgery is an emerging trend in the market. For instance, the viscoadpative OVDs have the combined benefit of cohesive and dispersive OVDs contained in a single syringe suitable for complex cataract surgery and ocular trauma cases.

Ophthalmic Viscosurgical Devices Market Report Highlights:

Based on the type, as cohesive and dispersive OVDs are used concomitantly in ocular surgical procedures they together held significant share in the market. In addition, the viscoadaptive OVDs segment is expected to register a healthy CAGR over the forecast period, attributed to factors such as improved surgical outcomes on usage of viscoadpative OVD coupled with increasing number of complex ocular procedures.
Based on application, the cataract surgery segment held the largest market share in 2023 and is expected to grow at a significant rate over the forecast period. Rising prevalence of diabetes, expanding geriatric population, favorable eye care policies are some of the factors expected to fuel the growth. Expanding OVDs application into ocular surgeries such as glaucoma and vitrectomy surgery are expected to witness growth, driving the market growth.
North America held the largest ophthalmic viscosurgical devices market share in 2023. Asia pacific is expected to expand at a speediest CAGR over the forecast period due to the improving access to ophthalmic care facilities and presence of large patient pool.
Viscoelastics derived from synthetic sources is expected to grow at a lucrative rate over the forecast period. This can be attributed to its low purification cost, high percentage of yield and easy extraction process compared to viscoelastic from animal source. The emerging trend is genetically engineering host bacteria to produce viscoelastic with low level of endotoxins thereby enhanced purity.

Product Code: GVR-3-68038-887-9

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Ophthalmic Viscosurgical Devices Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Ophthalmic Viscosurgical Devices Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Ophthalmic Viscosurgical Devices Market: Type Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Ophthalmic Viscosurgical Devices Market: Type Movement Analysis, 2023 & 2030 (USD Million)
4.3. Dispersive
- 4.3.1. Dispersive Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Cohesive
- 4.4.1. Cohesive Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Viscoadaptive
- 4.5.1. Viscoadaptive Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Ophthalmic Viscosurgical Devices Market: Source Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Ophthalmic Viscosurgical Devices Market: Source Movement Analysis, 2023 & 2030 (USD Million)
5.3. Animal
- 5.3.1. Animal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Biological
- 5.4.1. Biological Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Semi-synthetic
- 5.5.1. Semi-synthetic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Ophthalmic Viscosurgical Devices Market: Application Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Ophthalmic Viscosurgical Devices Market: Application Movement Analysis, 2023 & 2030 (USD Million)
6.3. Cataract Surgery
- 6.3.1. Cataract Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Glaucoma Surgery
- 6.4.1. Glaucoma Surgery Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Corneal Grafting
- 6.5.1. Corneal Grafting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Vitreoretinal Grafting
- 6.6.1. Vitreoretinal Grafting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Ophthalmic Viscosurgical Devices Market: Regional Estimates & Trend Analysis

7.1. Ophthalmic Viscosurgical Devices Market Share, By Region, 2023 & 2030, USD Million
7.2. North America
- 7.2.1. North America Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.2. U.S.
  - 7.2.2.1. U.S. Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.3. Canada
  - 7.2.3.1. Canada Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.4. Mexico
  - 7.2.4.1. Mexico Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
- 7.3.1. Europe Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. UK
  - 7.3.2.1. UK Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Germany
  - 7.3.3.1. Germany Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.4. France
  - 7.3.4.1. France Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.5. Italy
  - 7.3.5.1. Italy Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.6. Spain
  - 7.3.6.1. Spain Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.7. Denmark
  - 7.3.7.1. Denmark Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.8. Sweden
  - 7.3.8.1. Sweden Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.9. Norway
  - 7.3.9.1. Norway Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
- 7.4.1. Asia Pacific Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. China
  - 7.4.2.1. China Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Japan
  - 7.4.3.1. Japan Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. India
  - 7.4.4.1. India Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.5. South Korea
  - 7.4.5.1. South Korea Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.6. Australia
  - 7.4.6.1. Australia Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.7. Thailand
  - 7.4.7.1. Thailand Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
- 7.5.1. Latin America Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. Brazil
  - 7.5.2.1. Brazil Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Argentina
  - 7.5.3.1. Argentina Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
- 7.6.1. Middle East and Africa Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. South Africa
  - 7.6.2.1. South Africa Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. Saudi Arabia
  - 7.6.3.1. Saudi Arabia Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. UAE
  - 7.6.4.1. UAE Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. Kuwait
  - 7.6.5.1. Kuwait Ophthalmic Viscosurgical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
- 8.4.1. Bausch + Lomb
  - 8.4.1.1. Participant's Overview
  - 8.4.1.2. Financial Performance
  - 8.4.1.3. Product Benchmarking
  - 8.4.1.4. Recent Developments/ Strategic Initiatives
- 8.4.2. Carl Zeiss Meditec AG
  - 8.4.2.1. Participant's Overview
  - 8.4.2.2. Financial Performance
  - 8.4.2.3. Product Benchmarking
  - 8.4.2.4. Recent Developments/ Strategic Initiatives
- 8.4.3. Johnson & Johnson Services, Inc.
  - 8.4.3.1. Participant's Overview
  - 8.4.3.2. Financial Performance
  - 8.4.3.3. Product Benchmarking
  - 8.4.3.4. Recent Developments/ Strategic Initiatives
- 8.4.4. Alcon
  - 8.4.4.1. Participant's Overview
  - 8.4.4.2. Financial Performance
  - 8.4.4.3. Product Benchmarking
  - 8.4.4.4. Recent Developments/ Strategic Initiatives
- 8.4.5. Rayner Group
  - 8.4.5.1. Participant's Overview
  - 8.4.5.2. Financial Performance
  - 8.4.5.3. Product Benchmarking
  - 8.4.5.4. Recent Developments/ Strategic Initiatives
- 8.4.6. Bohus BioTech AB
  - 8.4.6.1. Participant's Overview
  - 8.4.6.2. Financial Performance
  - 8.4.6.3. Product Benchmarking
  - 8.4.6.4. Recent Developments/ Strategic Initiatives
- 8.4.7. BVI
  - 8.4.7.1. Participant's Overview
  - 8.4.7.2. Financial Performance
  - 8.4.7.3. Product Benchmarking
  - 8.4.7.4. Recent Developments/ Strategic Initiatives
- 8.4.8. Nordic Pharma, Inc.
  - 8.4.8.1. Participant's Overview
  - 8.4.8.2. Financial Performance
  - 8.4.8.3. Product Benchmarking
  - 8.4.8.4. Recent Developments/ Strategic Initiatives
- 8.4.9. Truviz Ophthalmic
  - 8.4.9.1. Participant's Overview
  - 8.4.9.2. Financial Performance
  - 8.4.9.3. Product Benchmarking
  - 8.4.9.4. Recent Developments/ Strategic Initiatives

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ